Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 2:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 613 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: iron Clear all

Conditions: Iron Deficiency Anemia
Interventions: ferumoxytol; Drug
Lead sponsor: Auerbach Hematology Oncology Associates P C; Other
Eligibility: 18 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bleeding Disorders, Iron, Platelet, Bleeding
Interventions: IV Iron (standard of care); Drug
Lead sponsor: Nicoletta C Machin; Other
Eligibility: 15 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Beta-thalassemia, Iron Overload
Interventions: Deferasirox; Drug
Lead sponsor: Novartis; Industry
Eligibility: 10 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 3
States / cities: Los Angeles, California • Oakland, California • Chicago, Illinois

Conditions: Transfusional Iron Overload
Interventions: ICL670; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 2 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 8
States / cities: Oakland, California • Orange, California • Boston, Massachusetts + 4 more

Conditions: Acute Radiation Syndrome
Interventions: RadProtect®; Drug
Lead sponsor: Original BioMedicals Co. Ltd.; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Iron-deficiency, Iron Deficiency Anemia
Interventions: Meal; Other
Lead sponsor: Florida State University; Other
Eligibility: Not listed
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Sickle Cell Disease
Interventions: Deferoxamine, Deferasirox, Deferiprone, Echocardiography, Electrocardiogram (ECG); Drug · Device
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Fairfax, Virginia • Falls Church, Virginia

Conditions: End Stage Renal Disease, Anemia
Interventions: Roxadustat, Epoetin Alfa, Placebo; Drug · Other
Lead sponsor: Kyntra Bio; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 25
States / cities: Tempe, Arizona • Pine Bluff, Arkansas • Azusa, California + 22 more

Conditions: Beta-Thalassemia
Interventions: LJPC-401; Drug
Lead sponsor: La Jolla Pharmaceutical Company; Industry
Eligibility: 14 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Oakland, California • New York, New York

Conditions: Pregnancy Related, Iron Deficiency Anemia of Pregnancy
Interventions: Ferrous sulfate; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Iron Deficiency Anemia
Interventions: Non-fortified rice, Iron-fortified Rice; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Heart Failure With Preserved Ejection Fraction, Iron Deficiency
Interventions: Ferric derisomaltose, Placebo (normal saline); Drug
Lead sponsor: Duke University; Other
Eligibility: 65 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pain
Interventions: Sham rTMS, Real rTMS; Procedure
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 45 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Infant Development
Interventions: BBN, Brand; Other
Lead sponsor: Building Block Nutritionals, LLC; Industry
Eligibility: 1 Day to 14 Days
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Iron Deficiency Anemia of Pregnancy
Interventions: Venofer 200 MG Per 10 ML Injection, Ferrous sulfate; Drug
Lead sponsor: Arrowhead Regional Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 518 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Colton, California

Conditions: Iron Deficiency, Anaemia
Interventions: Ferric carboxymaltose; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: Up to 1 Year
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 4
States / cities: Iowa City, Iowa • New Hyde Park, New York • Columbus, Ohio + 1 more

Conditions: Anemia
Interventions: ferumoxytol or oral iron; Drug
Lead sponsor: AMAG Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 19
States / cities: Encino, California • Riverside, California • Tarzana, California + 15 more

Conditions: Iron, Diabetes, Nonalcoholic Fatty Liver
Interventions: Blood Donation, Sham Blood Donation; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 40 Years to 75 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Winston-Salem, North Carolina

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Anemia, Neonatal
Interventions: Erythropoietin, Sham Comparator; Drug · Other
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 24 Hours to 96 Days
Enrollment: 318 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2000
U.S. locations: 9
States / cities: New Haven, Connecticut • Washington D.C., District of Columbia • Atlanta, Georgia + 6 more

Conditions: Infant Development
Interventions: Infant Formula; Other
Lead sponsor: Aussie Bubs, Inc.; Industry
Eligibility: 1 Day to 14 Days
Enrollment: 518 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 29
States / cities: Phoenix, Arizona • Centennial, Colorado • Jacksonville, Florida + 25 more

Conditions: Chronic Kidney Disease, Anemia of Chronic Disease
Interventions: Oral Calcitriol 0.5 mcg once daily for 6 weeks, Placebo; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Ligament Injury
Interventions: Oral Contraceptive Pill, norethindrn a-e estradiol-iron; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Iron Absorption
Interventions: Stable iron isotope; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Baton Rouge, Louisiana • Ithaca, New York

Conditions: Erythropoietic Protoporphyria, EPP, X-linked Protoporphyria, XLP
Interventions: Oral Iron; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 6
States / cities: Birmingham, Alabama • San Francisco, California • New York, New York + 3 more

Search by objective public record fields.

Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers

Iron Absorption and Exercise

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia

Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

Pilot Study of the Effect of Iron Fortified Rice in Iron Deficient Anemic Women

IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency

Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia

Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants

Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants

Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas

Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease

Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes

Dietary Iron Requirements

Oral Iron for Erythropoietic Protoporphyrias